Company news

MediWound Ltd. news in 2026

MediWound Ltd.'s news releases, calls and decks from 2026, newest first.

View company

MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares

November 5, 2026

MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares

November 3, 2026

MediWound to Report Third Quarter 2026 Financial Results

October 29, 2026

MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®

September 22, 2026

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

September 14, 2026

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 2, 2026

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 13, 2026

MediWound to Report Second Quarter 2026 Financial Results

July 29, 2026

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 27, 2026

MediWound to Report First Quarter 2026 Financial Results

May 7, 2026

Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement

April 13, 2026

MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

April 1, 2026

MediWound Reports Fourth Quarter and Full Year 2025 Financial Results

March 4, 2026

MediWound Files Annual Report on Form 20-F

March 4, 2026

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

February 19, 2026

MediWound to Present at Upcoming Investor Conferences

February 17, 2026

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

January 12, 2026

Calls in 2026

Decks in 2026